Oh, C. R., Kong, S., Im, H., Kim, H. J., Kim, M. K., Yoon, K., . . . Ryoo, B. (2019). Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib. BMC Cancer.
Chicago-стиль цитированияOh, Chung Ryul, et al. "Genome-wide Copy Number Alteration and VEGFA Amplification of Circulating Cell-free DNA As a Biomarker in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib." BMC Cancer 2019.
MLA-цитированиеOh, Chung Ryul, et al. "Genome-wide Copy Number Alteration and VEGFA Amplification of Circulating Cell-free DNA As a Biomarker in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib." BMC Cancer 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.